This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For veterans that have had an in-person visit with Veterans Affairs' providers, the Drug Enforcement Administration is extending those provider-patient relationships to all VA practitioners engaging in telemedicine with the patient, DEA said in a statement Friday.
For any practitioner-patient telemedicine relationships that have been or will be established up to November 11, 2023, the full set of telemedicine flexibilities regarding the prescription of controlled medications established during the COVID-19 PHE will be extended for one year – through November 11, 2024.
The COVID-19 pandemic has exacerbated this overdose crisis , and efforts are urgently needed to mitigate harm. Policies to mitigate the drug overdose crisis continue to fall short, as evidenced by increasing rates of opioid-involved overdoses and deaths in the United States.
Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public Health Emergency, which is set to expire on May 11.
Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023).
Establishes a COVID-19 Task Force to examine the origins of COVID-19 and to examine the country’s response at the Federal, state and local levels. The commission would make recommendations to the Administration and Congress, and its members would be field experts appointed by Congress.
The nation’s experience with COVID-19 demonstrated the need for increased telemedicine options for the treatment of substance use, especially in suburban and rural areas where health provider closures may severely limit access to care.
On January 12, 2023, the Drug Enforcement Administration (DEA) confirmed in a letter to registrants that the Consolidated Appropriations Act of 2023 (P.L. The Substance Abuse and Mental HealthServicesAdministration (SAMHSA) also issued a statement on its website on the removal of the DATA-Waiver. What this Means.
The most common reason that people with an unmet need for mental health care go without it is that they cannot afford the cost of care, according to a national survey conducted by the Substance Abuse and Mental HealthServicesAdministration.
“No matter the actual number of service hours, as illustrated above and below,” the Justice Department wrote, “existing staffing appears inadequate to ensure timely access to various types of care.” COVID-19 response from Wellpath and H.I.G. As part of that effort, a letter was sent to H.I.G. In a response letter, H.I.G.
Under the Second Temporary Rule, practitioners may continue to prescribe schedule II-V controlled medications via telemedicine for new and existing patients without conducting a prior in-person medical evaluation through 2024.
News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the public health emergency, through November 11.
COVID-19 thoroughly dominated American life last year, contributing heavily to the kind of despair that drives drug overdose deaths, which soared last year as well. Although the number is a fraction of the nearly 600,000 American COVID-19 deaths to date, it’s still a lot of grief. David Brzozowski Sr., said in December.
Prior to the federal COVID-19 Public Health Emergency (PHE), to initiate treatment with buprenorphine at an OTP, a practitioner needed to perform a complete in-person physical evaluation. Background and History of Medicare Telehealth Coverage of SUD Treatment. Want to Learn More?
Telemedicine Prescribing During the COVID-19 PHE During the COVID-19 PHE, among many other regulatory flexibilities, federal and state prescribing requirements were relaxed. 19, 2021), [link] [6] U.S. This deadline came and went, also without meaningful action taken by DEA. 21 U.S.C. § 15, 2021), [link] [7] U.S.
Currently, thirty-three states link financial incentives to mental health disparity metrics, representing a concerted recognition of the strategy’s effectiveness in addressing the increasing need for mental health treatment. [8] 2022 COVID-19 Practitioner Impact Survey. 8] FOOTNOTES [1] American Psychological Association.
The high level summary below of some of the Act’s more notable components that are significant in the healthcare arena is not meant to be an exhaustive list of all health policy changes or provisions included in the Act. increase in the Medicare conversion factor for CY 2023 and a 1.25% increase for CY 2024 for physician services. [18]
Funding for the Centers for Medicare and Medicaid Services will increase by $100 million, the National Institutes of Health will receive an additional $2.5 This will help to ensure that telehealth and hospital-at-home programs can continue to provide convenient and accessible medical treatment for patients.
In November 2022, OCR and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) issued a Notice of Proposed Rulemaking (NPRM) which sees both Part 2 and HIPAA changes to better align these regulations. HIPAA Changes Due to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19.
trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. Agencies Funding Levels/Description Advanced Research Projects Agency for Health (ARPA-H) $1.5
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content